Chen A, Chen Z, Xia Y, et al
In 2026, oral Wegovy became the first FDA-approved GLP-1 pill specifically indicated for weight loss
These terms are often used interchangeably in the literature to describe the histopathological findings of BBS, probably because of the indeterminate distinction on tissue sections
It is worth noting that UK and European medicines regulators (MHRA and EMA) continue to monitor reports of neuropsychiatric events with GLP-1 receptor agonists through their pharmacovigilance systems, but no causal association has been established at this time
Keeping a symptom diary noting when mood changes occur, their severity, and any potential triggers (such as timing relative to injections, meals, or blood sugar levels) can provide valuable information for your healthcare team
H value = 3.90), all treatments showed a significantly greater TBWL% versus placebo except for orlistat (Fig